Value investing is always a very popular strategy, and for good reason. After all, who doesn’t want to find stocks that have low PEs, solid outlooks, and decent dividends?
Fortunately for investors looking for this combination, we have identified a strong candidate which may be an impressive value; Herman Miller, Inc. .
Herman Miller in Focus
MLHR may be an interesting play thanks to its forward PE of 15.2, its P/S ratio of 0.8, and its decent dividend yield of 6.6%. These factors suggest that Herman Miller is a pretty good value pick, as investors have to pay a relatively low level for each dollar of earnings, and that MLHR has decent revenue metrics to back up its earnings.
But before you think that Herman Miller is just a pure value play, it is important to note that it has been seeing solid activity on the earnings estimate front as well. For current year earnings, the consensus has gone up by 9.1% in the past 30 days, thanks to two upward revisions in the past one month compared to none lower.
This estimate strength is actually enough to push MLHR to a Zacks Rank #2 (Buy), suggesting it is poised to outperform. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
So really, Herman Miller is looking great from a number of angles thanks to its PE below 20, a P/S ratio below one, and a strong Zacks Rank, meaning that this company could be a great choice for value investors at this time.
More Stock News: 8 Companies Verge on Apple-Like Run
Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs.
A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains. Click to see them right now >>
Image: Bigstock
Is Herman Miller (MLHR) Stock A Great Combo of Value and Growth?
Value investing is always a very popular strategy, and for good reason. After all, who doesn’t want to find stocks that have low PEs, solid outlooks, and decent dividends?
Fortunately for investors looking for this combination, we have identified a strong candidate which may be an impressive value; Herman Miller, Inc. .
Herman Miller in Focus
MLHR may be an interesting play thanks to its forward PE of 15.2, its P/S ratio of 0.8, and its decent dividend yield of 6.6%. These factors suggest that Herman Miller is a pretty good value pick, as investors have to pay a relatively low level for each dollar of earnings, and that MLHR has decent revenue metrics to back up its earnings.
Herman Miller, Inc. PE Ratio (TTM)
Herman Miller, Inc. PE Ratio (TTM) | Herman Miller, Inc. Quote
But before you think that Herman Miller is just a pure value play, it is important to note that it has been seeing solid activity on the earnings estimate front as well. For current year earnings, the consensus has gone up by 9.1% in the past 30 days, thanks to two upward revisions in the past one month compared to none lower.
This estimate strength is actually enough to push MLHR to a Zacks Rank #2 (Buy), suggesting it is poised to outperform. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
So really, Herman Miller is looking great from a number of angles thanks to its PE below 20, a P/S ratio below one, and a strong Zacks Rank, meaning that this company could be a great choice for value investors at this time.
More Stock News: 8 Companies Verge on Apple-Like Run
Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs.
A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains. Click to see them right now >>